To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after primary PCI. Forty-one patients undergoing primary PCI were randomly ...

Streptokinase plays a vital role in the management of severe acute pancreatitis, as per the new study. Detailing about the study, Rajesh Gupta, Professor and Head, Department of Surgical ...

Istanbul, Turkey - Administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term left ventricular size or function in a new ...

Of 27 patients with long standing arterial occlusions treated with streptokinase, reconstitution of flow in the external iliac and femoral arteries occurred in 17, confirming an earlier report ...

The study, published in the May 2005 issue of the European Heart Journal, tested streptokinase activity in 16 preparations of the drug produced by 11 manufacturers based in six countries ...

Streptokinase is an enzyme which works to break up and dissolve blood clots which can block arteries. It is mostly used in the treatment of heart attack or lung blood clots (pulmonary embolism).

Streptokinase (Streptokinase) is an enzyme, prescribed for heart attack, pulmonary embolism and deep vein thrombosis. It breaks up and dissolves blood clots that can block arteries. The ...

Streptokinase, a commonly used thrombolytic agent, is a nonenzymatic protein produced by beta-haemolytic streptococci. It has been associated with several allergic reactions including bronchospasm ...

All act by promoting the activity of circulating plasminogen. There is a long history of use of one, streptokinase, whereas the other three, alteplase, reteplase and tenecteplase, are newer options.

Clots obtained from patients diagnosed as suffering from Buerger's disease were exposed to varying concentrations of streptokinase (‘Varidase’; Lederle Laboratories) as were clots obtained ...